Phio Pharmaceuticals Corp.
$1.27
▼
-1.54%
2026-04-21 08:50:00
phiopharma.com
NCM: PHIO
Explore Phio Pharmaceuticals Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$14.75 M
Current Price
$1.27
52W High / Low
$4.19 / $0.81
Stock P/E
—
Book Value
$1.73
Dividend Yield
—
ROCE
-45.76%
ROE
-69.95%
Face Value
—
EPS
$-1.45
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
6
Beta
0.81
Debt / Equity
—
Current Ratio
16.03
Quick Ratio
16.03
Forward P/E
-1.95
Price / Sales
—
Enterprise Value
$-6.97 M
EV / EBITDA
0.76
EV / Revenue
—
Rating
None
Target Price
$14
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Lisata Therapeutics, Inc. | $2.83 | — | $25.56 M | — | -124.1% | -75.53% | $5.07 / $1.81 | $1.68 |
| 2. | OSR Holdings, Inc. | $0.6 | — | $19.87 M | — | 79.82% | -20.03% | $1.79 / $0.38 | $3.46 |
| 3. | Ernexa Therapeutics Inc. | $0.19 | — | $5.87 M | 0.34% | -342.48% | -6.87% | $4.05 / $0.18 | $0.31 |
| 4. | Oragenics, Inc. | $0.71 | — | $3.19 M | — | -113.05% | -2.44% | $9.6 / $0.5 | $1.94 |
| 5. | Maravai LifeSciences Holdings, Inc. | $3.61 | — | $928.01 M | — | -17.71% | -48.59% | $4.11 / $1.67 | $1.46 |
| 6. | Tango Therapeutics, Inc. | $26.39 | — | $3.8 B | — | -29.52% | -37.23% | $26.81 / $1.03 | $2.55 |
| 7. | Eupraxia Pharmaceuticals Inc. | $7.2 | — | $599.04 M | — | -47.73% | -68.76% | $12.86 / $4.38 | $1.01 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -2.53 M | -2.5 M | -2.31 M | -1.87 M | -1.67 M | — |
| Net Profit | -2.37 M | -2.39 M | -2.17 M | -1.77 M | -1.63 M | — |
| EPS in Rs | -0.2 | -0.21 | -0.19 | -0.15 | -0.14 | -1.54 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -9.22 M | -7.39 M | -10.7 M | -11.46 M |
| Net Profit | -8.7 M | -7.15 M | -10.83 M | -11.48 M |
| EPS in Rs | -0.75 | -0.62 | -0.93 | -0.99 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 21.49 M | 5.74 M | 9.36 M | 12.81 M |
| Total Liabilities | 1.34 M | 1.01 M | 1.63 M | 1.98 M |
| Equity | 20.15 M | 4.72 M | 7.73 M | 10.84 M |
| Current Assets | 21.48 M | 5.74 M | 9.32 M | 12.45 M |
| Current Liabilities | 1.34 M | 1.01 M | 1.63 M | 1.94 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -7.98 M | -7.11 M | -10.75 M | -12.13 M |
| Investing CF | -0.01 M | 0.01 M | -0.01 M | -0.12 M |
| Financing CF | 23.64 M | 4 M | 7.41 M | -0.03 M |
| Free CF | -7.99 M | -7.11 M | -10.75 M | -12.25 M |
| Capex | -0.01 M | -0 M | -0.01 M | -0.12 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 33.96% | 5.7% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-07-05 | 1:0.111111 |
| 2023-01-26 | 1:0.0833333 |